MetaADEDB 2.0 @ LMMD
bromfenac
(ZBPLOVFIXSTCRZ-UHFFFAOYSA-N)
Structure
SMILES
OC(=O)Cc1cccc(c1N)C(=O)c1ccc(cc1)Br
Type(s)
Approved
ATC code(s)
S01BC11
Molecular Formula:
C15H12BrNO3
Molecular Weight:
334.165
Log P:
3.4706
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
80.39
CAS Number(s):
91714-94-2; 120638-55-3
Synonym(s)
1.
bromfenac
2.
AHR-10282
3.
Duract
4.
ISV-303
5.
Xibrom
6.
bromfenac sodium
7.
sodium bromfenac
External Link(s)
MeSHC053083
PubChem Compound60726
BindingDB50248104
ChEBI240107
CHEMBLCHEMBL1077
DrugBankDB00963
DrugCentral401
IUPHAR/BPS Guide to PHARMACOLOGY7131
KEGGdr:D07541
Therapeutic Target DatabaseD0U1OM
ZINC2570817
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Eye irritationFAERS: 22SIDER
US FAERS
2Eye painFAERS: 15SIDER
US FAERS
3No adverse eventFAERS: 8US FAERS
4Foreign body sensation in eyesFAERS: 6US FAERS
5DizzinessFAERS: 5US FAERS
6PruritusFAERS: 5US FAERS
7BlepharitisFAERS: 4US FAERS
8Cataract operationFAERS: 4US FAERS
9HeadacheFAERS: 4SIDER
US FAERS
10Swelling of eyelidFAERS: 4US FAERS
11Visual ImpairmentFAERS: 4US FAERS
12Drug ineffectiveFAERS: 3US FAERS
13Expired product administeredFAERS: 3US FAERS
14Feeling abnormalFAERS: 3US FAERS
15Drug administration errorFAERS: 2US FAERS
16Eye InfectionFAERS: 2US FAERS
17Incorrect drug administration durationFAERS: 2US FAERS
18KeratitisFAERS: 2US FAERS
19Medication residue presentFAERS: 2US FAERS
20NauseaFAERS: 2US FAERS
21Oropharyngeal painFAERS: 2US FAERS
22PhotophobiaFAERS: 2SIDER
US FAERS
23TinnitusFAERS: 2US FAERS
24Accidental exposure to productFAERS: 1US FAERS
25AgitationFAERS: 1US FAERS
26Angina PectorisFAERS: 1US FAERS
27Anterior chamber inflammationFAERS: 1SIDER
US FAERS
28AsthenopiaFAERS: 1US FAERS
29BlindnessFAERS: 1US FAERS
30Blood iron decreasedFAERS: 1US FAERS
31Burning sensationFAERS: 1US FAERS
32Caustic injuryFAERS: 1US FAERS
33ChromaturiaFAERS: 1US FAERS
34ConjunctivitisFAERS: 1US FAERS
35Corneal erosionFAERS: 1SIDER
US FAERS
36Deposit eyeFAERS: 1US FAERS
37Drug effect incompleteFAERS: 1US FAERS
38Drug prescribing errorFAERS: 1US FAERS
39Extra dose administeredFAERS: 1US FAERS
40Eye inflammationFAERS: 1US FAERS
41Eyelid margin crustingFAERS: 1US FAERS
42Eyelid painFAERS: 1US FAERS
43Facial PainFAERS: 1US FAERS
44FatigueFAERS: 1US FAERS
45HypersensitivityFAERS: 1US FAERS
46Impaired driving abilityFAERS: 1US FAERS
47Inappropriate schedule of product administrationFAERS: 1US FAERS
48Incorrect dose administeredFAERS: 1US FAERS
49Instillation site erythemaFAERS: 1US FAERS
50Instillation site painFAERS: 1US FAERS
51Joint swellingFAERS: 1US FAERS
52Limb operationFAERS: 1US FAERS
53Macular degenerationFAERS: 1US FAERS
54MydriasisFAERS: 1US FAERS
55Ocular discomfortFAERS: 1SIDER
US FAERS
56OverdoseFAERS: 1US FAERS
57PallorFAERS: 1US FAERS
58Peripheral swellingFAERS: 1US FAERS
59Product dropper issueFAERS: 1US FAERS
60Product physical consistency issueFAERS: 1US FAERS
61Product quality issueFAERS: 1US FAERS
62Reaction to preservativesFAERS: 1US FAERS
63Retinal Vein OcclusionFAERS: 1US FAERS
64Scleral thinningFAERS: 1US FAERS
65SneezingFAERS: 1US FAERS
66SomnolenceFAERS: 1US FAERS
67Throat irritationFAERS: 1US FAERS
68TremorFAERS: 1US FAERS
69UlcerFAERS: 1US FAERS
70UrticariaFAERS: 1US FAERS
71WheezingFAERS: 1US FAERS
72AsthmaSIDER
73Chemical and Drug Induced Liver Injury

View details

CTD
74Corneal PerforationSIDER
75Corneal ScarSIDER
76Corneal epithelium defectSIDER
77Corneal epithelium disorderSIDER
78Corneal thinningSIDER
79EpistaxisSIDER
80Eye RednessSIDER
81IritisSIDER
82Liver Failure, Acute10445569CTD
83Nasal sinus drainageSIDER
84PainSIDER
85Retinal exudatesSIDER
86ScleromalaciaSIDER
87Sinus operationSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.